Our results showed that the expression GBP2 was significantly and positively correlated with both the expression of most immune checkpoints (such as PD-1 and PD-L1) and the distribution of CD8+ T cells in the RCC tumor microenvironment. This evidence concerns the gene GBP2 and renal cell carcinoma.